{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:22:01Z","timestamp":1791778921341,"version":"4.3.4"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Chronic pain is widely recognized as a major global health problem that affects approximately one-fifth of the adult population and is associated with significant physical, psychological, and socioeconomic burden. Current clinical analgesic strategies are mainly based on non-steroidal anti-inflammatory drugs, opioids, and adjuvant agents including antidepressants and antiepileptic drugs. However, these therapies are limited by insufficient efficacy in neuropathic pain, considerable adverse effects, and the risks of tolerance and addiction. Therefore, the development of safer and more effective non-opioid analgesics remains an important unmet clinical need. Nicotinic acetylcholine receptors (nAChRs) have been identified as promising targets for the development of next-generation analgesics because of their roles in pain signal transmission, neuroinflammation, and immune\u2013neural interactions. nAChRs are pentameric ligand-gated ion channels composed of different subunit combinations, which give rise to multiple receptor subtypes with distinct expression patterns and functional properties. Increasing evidence suggests that specific nAChR subtypes, including \u03b13\u03b24, \u03b14\u03b22, \u03b16\u03b24, \u03b19\u03b110, and \u03b17, participate in the regulation of inflammatory pain, neuropathic pain, and cancer-related pain. This review summarizes recent progress in the understanding of subtype-specific roles of nAChRs in pain regulation. The development of highly selective tool compounds, particularly \u03b1-conotoxin-derived peptides, is discussed together with current knowledge regarding the mechanisms associated with nAChR-mediated analgesia. Challenges related to clinical translation and potential therapeutic strategies are also considered.<\/jats:p>","DOI":"10.3389\/fphar.2026.1782495","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:12:08Z","timestamp":1779430328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Nicotinic acetylcholine receptors in pain modulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Junya","family":"Cheng","sequence":"first","affiliation":[{"name":"Changchun Institute of Biological Products Co., Ltd.","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Chang","sequence":"additional","affiliation":[{"name":"Changchun Institute of Biological Products Co., Ltd.","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Li","sequence":"additional","affiliation":[{"name":"Changchun Institute of Biological Products Co., Ltd.","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1021\/acschemneuro.5c00216","article-title":"The functional topology of phenylpiperazinium agonists and antagonists on the nicotinic acetylcholine receptor landscape: pointing the way for future therapeutic management of inflammation and neuropathic pain","volume":"16","author":"Andleeb","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e24223","DOI":"10.1002\/pep2.24223","article-title":"Ziconotide (\u03c9-conotoxin MVIIA)\u2014Efficient solid-phase synthesis of a linear precursor peptide and its strategic native folding","volume":"113","author":"Aridoss","year":"2021","journal-title":"Peptide Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bpa.2013.10.007","article-title":"Pain management for the cancer patient - current practice and future developments","volume":"27","author":"Auret","year":"2013","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/14737159.2022.2093638","article-title":"Molecular monitoring of patient response to painkiller drugs","volume":"22","author":"Ayuso","year":"2022","journal-title":"Expert Rev. Mol. Diagn"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1471-4159.2012.07867.x","article-title":"Molecular basis for the differential sensitivity of rat and human \u03b19\u03b110 nAChRs to \u03b1-conotoxin RgIA","volume":"122","author":"Azam","year":"2012","journal-title":"J. Neurochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/acsptsci.4c00454","article-title":"\u03b19-containing nicotinic acetylcholine receptors are required for RgIA-5474 attenuation of chemotherapy-induced neuropathic pain","volume":"7","author":"Azam","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/bph.13761","article-title":"Stimulation of na+ -K+ -pump currents by epithelial nicotinic receptors in rat Colon","volume":"174","author":"Bader","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ejp.1092","article-title":"Allosteric modulation of \u03b14\u03b22* nicotinic acetylcholine receptors: desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain","volume":"22","author":"Bagdas","year":"2018","journal-title":"Eur. J. Pain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/01616412.2021.1949684","article-title":"(E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by \u03b17 nicotinic acetylcholine receptor potentiation","volume":"43","author":"Bagdas","year":"2021","journal-title":"Neurol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.3390\/molecules26113373","article-title":"Venom-derived neurotoxins targeting nicotinic acetylcholine receptors","volume":"26","author":"Bekbossynova","year":"2021","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"166875","DOI":"10.1016\/j.bbadis.2023.166875","article-title":"Nicotinic acetylcholine receptors in cancer: limitations and prospects","volume":"1870","author":"Bele","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1128\/AAC.00840-10","article-title":"Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors","volume":"54","author":"Bertrand","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/membranes11090664","article-title":"Homomeric and heteromeric \u03b17 nicotinic acetylcholine receptors in health and some central nervous system diseases","volume":"11","author":"Borroni","year":"2021","journal-title":"Membranes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1113\/JP275101","article-title":"Molecular function of \u03b17 nicotinic receptors as drug targets","volume":"596","author":"Bouzat","year":"2018","journal-title":"J. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s13063-024-08387-0","article-title":"SPIDOL study protocol for the assessment of intrathecal ziconotide antalgic efficacy for severe refractory neuropathic pain due to spinal cord lesions","volume":"25","author":"Brinzeu","year":"2024","journal-title":"Trials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s11010-024-05032-x","article-title":"Protein networking: nicotinic acetylcholine receptors and their protein-protein-associations","volume":"479","author":"Brockm\u00f6ller","year":"2024","journal-title":"Mol. Cell Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0014-5793(73)80171-1","article-title":"Presence of a lattice structure in membrane fragments rich in nicotinic receptor protein from the electric organ of Torpedo marmorata","volume":"33","author":"Cartaud","year":"1973","journal-title":"FEBS Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1177\/0003134820952834","article-title":"Are NSAIDs safe? Assessing the risk-benefit profile of nonsteroidal anti-inflammatory drug use in postoperative pain management","volume":"87","author":"Chang","year":"2021","journal-title":"Am. Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/biom10040547","article-title":"Discovery of the first neurotransmitter receptor: the acetylcholine nicotinic receptor","volume":"10","author":"Changeux","year":"2020","journal-title":"Biomolecules"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1111\/cns.14207","article-title":"Anti-neuroinflammation effects of transcutaneous auricular vagus nerve stimulation against depression-like behaviors via hypothalamic \u03b17nAchR\/JAK2\/STAT3\/NF-\u03baB pathway in rats exposed to chronic unpredictable mild stress","volume":"29","author":"Chen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"157684","DOI":"10.1016\/j.phymed.2025.157684","article-title":"Notopterol attenuates synovitis via \u03b17nAChR-dependent metabolic reprogramming of macrophage polarisation","volume":"150","author":"Chen","year":"2025","journal-title":"Phytomed Int. J. Phytother. Phytopharm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e25016","DOI":"10.1371\/journal.pone.0025016","article-title":"Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood\u2013brain barrier are modulated by Alpha7 nicotinic receptor","volume":"6","author":"Chi","year":"2011","journal-title":"PLOS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.6026\/973206300210571","article-title":"Regulation of inflammaging","volume":"21","author":"Chiappelli","year":"2025","journal-title":"Bioinformation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuropharm.2015.02.005","article-title":"Pharmacological stress is required for the anti-alcohol effect of the \u03b13\u03b24* nAChR partial agonist AT-1001","volume":"93","author":"Cippitelli","year":"2015","journal-title":"Neuropharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-7-35","article-title":"Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs","volume":"7","author":"Dash","year":"2014","journal-title":"Mol. Brain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1523\/JNEUROSCI.3197-15.2016","article-title":"Activation of alpha 7 cholinergic nicotinic receptors reduce blood\u2013brain barrier permeability following experimental traumatic brain injury","volume":"36","author":"Dash","year":"2016","journal-title":"J. Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1074\/jbc.M208814200","article-title":"A novel class of ligand-gated ion channel is activated by Zn2+","volume":"278","author":"Davies","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.pain.2014.06.023","article-title":"\u03b1-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement","volume":"155","author":"Di Cesare Mannelli","year":"2014","journal-title":"Pain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00213-017-4827-y","article-title":"Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test","volume":"235","author":"Ding","year":"2018","journal-title":"Psychopharmacol. Berl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1021\/acschemneuro.4c00760","article-title":"Prediction of specificity of \u03b1-conotoxins to subtypes of human nicotinic acetylcholine receptors with semi-supervised machine learning","volume":"16","author":"Do","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1523\/JNEUROSCI.0127-19.2020","article-title":"a3* nicotinic acetylcholine receptors in the habenula-interpeduncular nucleus circuit regulate nicotine intake","volume":"41","author":"Elayouby","year":"2021","journal-title":"J. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cca.2021.11.031","article-title":"Quantification of choline in serum and plasma using a clinical nuclear magnetic resonance analyzer","volume":"524","author":"Garcia","year":"2022","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e23374","DOI":"10.1096\/fj.202302079","article-title":"Analogs of \u03b1-conotoxin PnIC selectively inhibit \u03b17\u03b22-over \u03b17-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism","volume":"38","author":"George","year":"2024","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/bph.13838","article-title":"Understanding structure\u2013function relationships of the human neuronal acetylcholine receptor: insights from the first crystal structures of neuronal subunits","volume":"175","author":"Giastas","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"106801","DOI":"10.1016\/j.phrs.2023.106801","article-title":"Small molecule ligands for \u03b19 * and \u03b17 nicotinic receptors: a survey and an update, respectively","volume":"193","author":"Giraudo","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/1471-2458-11-770","article-title":"Pain as a global public health priority","volume":"11","author":"Goldberg","year":"2011","journal-title":"BMC Public Health"},{"key":"B37","doi-asserted-by":"publisher","first-page":"934906","DOI":"10.3389\/fcvm.2022.934906","article-title":"Muscarinic receptor regulation of chronic pain-induced atrial fibrillation","volume":"9","author":"Gong","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/cpt.794","article-title":"Cyclooxygenase inhibition: pain, inflammation, and the cardiovascular system","volume":"102","author":"Grosser","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/cells14130948","article-title":"Effects of selective \u03b17 nicotinic acetylcholine receptor stimulation in oligodendrocytes: putative implication in neuroinflammation","volume":"14","author":"Guerriero","year":"2025","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11916-016-0548-x","article-title":"Post-herpetic neuralgia: a review","volume":"20","author":"Hadley","year":"2016","journal-title":"Curr. Pain Headache Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2016.12.013","article-title":"Antinociceptive effect of tebanicline for various noxious stimuli-induced behaviours in mice","volume":"638","author":"Hayashi","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"745854","DOI":"10.3389\/fimmu.2021.745854","article-title":"Endogenous \u03b17 nAChR agonist SLURP1 facilitates Escherichia coli K1 crossing the blood-brain barrier","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ejphar.2011.08.053","article-title":"The novel small molecule \u03b19\u03b110 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic","volume":"670","author":"Holtman","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/1873-3468.12884","article-title":"Nicotinic acetylcholine receptors in neuropathic and inflammatory pain","volume":"592","author":"Hone","year":"2018","journal-title":"FEBS Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"106715","DOI":"10.1016\/j.phrs.2023.106715","article-title":"Nicotinic acetylcholine receptors: therapeutic targets for novel ligands to treat pain and inflammation","volume":"190","author":"Hone","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/bph.13931","article-title":"\u03b19-containing nicotinic acetylcholine receptors and the modulation of pain","volume":"175","author":"Hone","year":"","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17838","DOI":"10.1074\/jbc.RA118.005649","article-title":"Molecular determinants of \u03b1-conotoxin potency for inhibition of human and rat \u03b16\u03b24 nicotinic acetylcholine receptors","volume":"293","author":"Hone","year":"","journal-title":"J. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1021\/acs.jmedchem.0c01973","article-title":"Computational and functional mapping of human and rat \u03b16\u03b24 nicotinic acetylcholine receptors reveals species-specific ligand-binding motifs","volume":"64","author":"Hone","year":"2021","journal-title":"J. Med. Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1124\/mol.110.066381","article-title":"\u03b14\u03b22 nicotinic receptors partially mediate anti-inflammatory effects through janus kinase 2-signal transducer and activator of transcription 3 but not calcium or cAMP signaling","volume":"79","author":"Hosur","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1200\/JCO.18.01567","article-title":"Comparative efficacy of therapeutics for chronic cancer pain: a bayesian network meta-analysis","volume":"37","author":"Huang","year":"2019","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.3390\/cells11223561","article-title":"RgIA4 prevention of acute oxaliplatin-induced cold allodynia requires \u03b19-containing nicotinic acetylcholine receptors and CD3+ T-cells","volume":"11","author":"Huynh","year":"2022","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.01.017","article-title":"The \u03b13\u03b24* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the \u03b15 subunit in the mouse","volume":"70","author":"Jackson","year":"2013","journal-title":"Neuropharmacology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1021\/jm040219e","article-title":"Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations","volume":"48","author":"Jensen","year":"2005","journal-title":"J. Med. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00125-025-06640-y","article-title":"\u03b17 nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding","volume":"69","author":"Ji","year":"2025","journal-title":"Diabetologia"},{"key":"B56","doi-asserted-by":"publisher","first-page":"165980","DOI":"10.1016\/j.bbadis.2020.165980","article-title":"Excessive ROS production and enhanced autophagy contribute to myocardial injury induced by branched-chain amino acids: roles for the AMPK-ULK1 signaling pathway and \u03b17nAChR","volume":"1867","author":"Jiang","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1213\/ANE.0000000000002442","article-title":"Basic\/Translational development of forthcoming opioid- and nonopioid-targeted pain therapeutics","volume":"125","author":"Knezevic","year":"2017","journal-title":"Anesth. Analg."},{"key":"B58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrn.2017.5","article-title":"Structural plasticity and reorganisation in chronic pain","volume":"18","author":"Kuner","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"36252","DOI":"10.1038\/s41598-025-20109-3","article-title":"Assessing species-specific neonicotinoid toxicity using cross-species chimeric nicotinic acetylcholine receptors in a drosophila model","volume":"15","author":"Lassota","year":"2025","journal-title":"Sci. Rep."},{"key":"B60","volume-title":"2-(5-[11C]methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthene-9-one. Molecular imaging and contrast agent database (MICAD)","author":"Leung","year":"2004"},{"key":"B61","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pnpbp.2015.12.005","article-title":"Anti-hypersensitive effect of intramuscular administration of \u03b1O-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain","volume":"66","author":"Li","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol Biol. Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/md18120646","article-title":"\u03b1-conotoxin TxID and [S9K]TxID, \u03b13\u03b24 nAChR antagonists, attenuate expression and reinstatement of nicotine-induced conditioned place preference in mice","volume":"18","author":"Li","year":"2020","journal-title":"Mar. Drugs"},{"key":"B63","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1021\/acs.jmedchem.3c00979","article-title":"Dual antagonism of \u03b19\u03b110 nAChR and GABAB receptor-coupled CaV2.2 channels by an analgesic \u03b1O-conotoxin analogue","volume":"67","author":"Li","year":"","journal-title":"J. Med. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"18400","DOI":"10.1021\/acs.jmedchem.4c01758","article-title":"N-Terminal capping of the \u03b1O-Conotoxin analogue GeX-2 improves the serum stability and selectivity toward the human \u03b19\u03b110 nicotinic acetylcholine receptor","volume":"67","author":"Li","year":"","journal-title":"J. Med. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"16204","DOI":"10.1021\/acs.jmedchem.2c00494","article-title":"Mechanism of action and structure-activity relationship of \u03b1-conotoxin Mr1.1 at the human \u03b19\u03b110 nicotinic acetylcholine receptor","volume":"65","author":"Liang","year":"2022","journal-title":"J. Med. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1124\/mol.114.093179","article-title":"Subtype-specific mechanisms for functional interaction between \u03b16\u03b24* nicotinic acetylcholine receptors and P2X receptors","volume":"86","author":"Limapichat","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.3390\/ijms25126716","article-title":"New insight into neuropathic pain: the relationship between \u03b17nAChR, ferroptosis, and neuroinflammation","volume":"25","author":"Luo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"E4026","DOI":"10.1073\/pnas.1503617112","article-title":"Cloning, synthesis, and characterization of \u03b1O-conotoxin GeXIVA, a potent \u03b19\u03b110 nicotinic acetylcholine receptor antagonist","volume":"112","author":"Luo","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/md20080497","article-title":"Single-disulfide conopeptide Czon1107, an allosteric antagonist of the human \u03b13\u03b24 nicotinic acetylcholine receptor","volume":"20","author":"Ma","year":"2022","journal-title":"Mar. Drugs"},{"key":"B71","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/md20120773","article-title":"Conus regius-derived conotoxins: novel therapeutic opportunities from a marine organism","volume":"20","author":"Margiotta","year":"2022","journal-title":"Mar. Drugs"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1113\/JP285689","article-title":"\u03b14\u03b22* nicotinic acetylcholine receptors drive human temporal glutamate\/GABA balance toward inhibition","volume":"603","author":"Martinello","year":"2025","journal-title":"J. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1877718X241313373","article-title":"Cortical \u03b14\u03b22-nicotinic acetylcholine receptors and cognitive decline in parkinson\u2019s disease","volume":"15","author":"Mills","year":"2025","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1074\/jbc.RA119.012098","article-title":"Structure and allosteric activity of a single-disulfide conopeptide from Conus zonatus at human \u03b13\u03b24 and \u03b17 nicotinic acetylcholine receptors","volume":"295","author":"Mohan","year":"2020","journal-title":"J. Biol. Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3390\/ph16101363","article-title":"Exploring cholinergic compounds for peripheral neuropathic pain management: a comprehensive scoping review of rodent model studies","volume":"16","author":"Montign\u00e9","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/jnr.25239","article-title":"Apoptosis in the neuroprotective effect of \u03b17 nicotinic receptor in neurodegenerative models","volume":"101","author":"Mugayar","year":"2023","journal-title":"J. Neurosci. Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuroscience.2017.08.049","article-title":"Molecular, cellular and circuit basis of cholinergic modulation of pain","volume":"387","author":"Naser","year":"2018","journal-title":"Neuroscience"},{"key":"B79","doi-asserted-by":"publisher","first-page":"112908","DOI":"10.1016\/j.injury.2025.112908","article-title":"Effects of varenicline as an adjunct to analgesic and anti-inflammatory therapy in acute nerve injury","volume":"57","author":"Ozturk","year":"2026","journal-title":"Injury"},{"key":"B80","doi-asserted-by":"publisher","first-page":"108021","DOI":"10.1016\/j.neuropharm.2020.108021","article-title":"Nicotinic acetylcholine receptors: conventional and unconventional ligands and signaling","volume":"168","author":"Papke","year":"2020","journal-title":"Neuropharmacology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"106736","DOI":"10.1016\/j.phrs.2023.106736","article-title":"Silent agonists for \u03b17 nicotinic acetylcholine receptors","volume":"190","author":"Papke","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-2966552\/v1","article-title":"Regulation of LPS-Induced inflammatory responses in HMC3 microglia by nicotine and its neuroprotective effects","author":"Qin","year":"2023"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised international association for the study of pain definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"B84","doi-asserted-by":"publisher","first-page":"779081","DOI":"10.3389\/fncel.2022.779081","article-title":"Comparison of the anti-inflammatory properties of two nicotinic acetylcholine receptor ligands, phosphocholine and pCF3-diEPP","volume":"16","author":"Richter","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"E1825","DOI":"10.1073\/pnas.1621433114","article-title":"Inhibition of \u03b19\u03b110 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain","volume":"114","author":"Romero","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/bja\/aeq113","article-title":"Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain","volume":"105","author":"Rowley","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"B87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.brainres.2005.08.009","article-title":"Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones","volume":"1059","author":"Satkunanathan","year":"2005","journal-title":"Brain Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1124\/mol.61.1.150","article-title":"A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit","volume":"61","author":"Sgard","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/j.wneu.2020.10.079","article-title":"Effect of first-line ziconotide intrathecal drug therapy for neuropathic pain on disability, emotional well-being, and pain catastrophizing","volume":"145","author":"Shao","year":"2021","journal-title":"World Neurosurg."},{"key":"B90","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.3390\/ijms24076524","article-title":"\u03b17-and \u03b19-Containing nicotinic acetylcholine receptors in the functioning of immune system and in pain","volume":"24","author":"Shelukhina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fncel.2013.00225","article-title":"Comparative functional expression of nAChR subtypes in rodent DRG neurons","volume":"7","author":"Smith","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1038\/s41467-025-58333-0","article-title":"Molecular insights into the \u03b16\u03b24 nicotinic acetylcholine receptor function and ligand recognition","volume":"16","author":"Su","year":"2025","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1016\/j.neuron.2023.08.017","article-title":"A cholinergic circuit that relieves pain despite opioid tolerance","volume":"111","author":"Sullere","year":"2023","journal-title":"Neuron"},{"key":"B94","doi-asserted-by":"publisher","first-page":"177463","DOI":"10.1016\/j.ejphar.2025.177463","article-title":"Ethyl 4-(4-bromophenyl)-2-diazo-4-(formyloxy) butanoate exerts anti-inflammatory effects on RAW 264.7 cells and zebrafish through the activation of \u02517nAchR","volume":"997","author":"Tan","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1523\/JNEUROSCI.2781-11.2011","article-title":"Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca2+ channels and Ca2+ release from stores","volume":"31","author":"Tang","year":"2011","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1570159X22666240528161117","article-title":"The role of alpha-7 nicotinic acetylcholine receptors in pain: potential therapeutic implications","volume":"23","author":"Tao","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"107245","DOI":"10.1016\/j.nbd.2025.107245","article-title":"Astrocytic \u03b17-nicotinic acetylcholine receptors mediate pain information processing and perception","volume":"218","author":"Teng","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"113010","DOI":"10.1016\/j.expneurol.2019.113010","article-title":"The \u03b17 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal","volume":"320","author":"Toma","year":"2019","journal-title":"Exp. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/7854_2020_135","article-title":"Behavioral and molecular basis of cholinergic modulation of pain: focus on nicotinic acetylcholine receptors","volume":"45","author":"Toma","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/j.pain.0000000000000993","article-title":"Nicotinic modulation of descending pain control circuitry","volume":"158","author":"Umana","year":"2017","journal-title":"Pain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"107691","DOI":"10.1016\/j.neuropharm.2019.107691","article-title":"\u03b1-conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of \u03b16\u03b24* nicotinic acetylcholine receptors","volume":"157","author":"van Hout","year":"2019","journal-title":"Neuropharmacology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0116227","DOI":"10.1371\/journal.pone.0116227","article-title":"Two novel \u03b17 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice","volume":"10","author":"van Maanen","year":"2015","journal-title":"PLOS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1213\/ANE.0b013e31825a3c72","article-title":"Novel small molecule \u03b19\u03b110 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats","volume":"115","author":"Wala","year":"2012","journal-title":"Anesth. Analg."},{"key":"B102","doi-asserted-by":"publisher","first-page":"e13631","DOI":"10.1111\/apha.13631","article-title":"Nicotine and vascular dysfunction","volume":"231","author":"Whitehead","year":"2021","journal-title":"Acta Physiol. Oxf Engl."},{"key":"B103","doi-asserted-by":"publisher","first-page":"287ra72","DOI":"10.1126\/scitranslmed.3009986","article-title":"The nicotinic \u03b16 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2\/3 receptors","volume":"7","author":"Wieskopf","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/ijnp\/pyy021","article-title":"Brain PET imaging of \u03b17-nAChR with [18F]ASEM: reproducibility, occupancy, receptor density, and changes in schizophrenia","volume":"21","author":"Wong","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e00377","DOI":"10.1016\/j.neurot.2024.e00377","article-title":"A synthetic peptide exerts nontolerance-forming antihyperalgesic and antidepressant effects in mice","volume":"21","author":"Wu","year":"2024","journal-title":"Neurotherapeutics"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1038\/s41467-026-69001-2","article-title":"A molecularly defined basalo-prefrontal-thalamic circuit regulates sensory and affective dimensions of pain in Male mice","volume":"17","author":"Xie","year":"2026","journal-title":"Nat. Commun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1021\/acschemneuro.2c00048","article-title":"Cobratoxin alleviates cancer-induced bone pain in rats via inhibiting CaMKII signaling pathway after acting on M4 muscarinic cholinergic receptors","volume":"13","author":"Xu","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s10020-025-01387-z","article-title":"Nociceptor \u03b17nAChR activation blunts neuronal HMGB1 release and attenuates inflammation and nociceptive behavior","volume":"31","author":"Yang","year":"2025","journal-title":"Mol. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1021\/jm400041h","article-title":"Determination of the \u03b1-conotoxin Vc1.1 binding site on the \u03b19\u03b110 nicotinic acetylcholine receptor","volume":"56","author":"Yu","year":"2013","journal-title":"J. Med. Chem."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1111\/bph.14698","article-title":"Molecular dynamics simulations of dihydro-\u03b2-erythroidine bound to the human \u03b14\u03b22 nicotinic acetylcholine receptor","volume":"176","author":"Yu","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s10787-021-00873-0","article-title":"The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete freund\u2019s adjuvant-induced chronic inflammatory pain","volume":"29","author":"Zhang","year":"2021","journal-title":"Inflammopharmacology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"118300","DOI":"10.1016\/j.ejmech.2025.118300","article-title":"\u03b16 nicotinic acetylcholine receptors: a pharmacological challenge with untapped therapeutic promise","volume":"302","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/md17060342","article-title":"DSPE-PEG modification of \u03b1-conotoxin TxID","volume":"17","author":"Zhao","year":"2019","journal-title":"Mar. Drugs"},{"key":"B114","doi-asserted-by":"publisher","first-page":"970040","DOI":"10.3389\/fnmol.2022.970040","article-title":"Targeting \u03b17 nicotinic acetylcholine receptors for chronic pain","volume":"15","author":"Zhou","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/iub.170","article-title":"Recent advances in understanding the structure of nicotinic acetylcholine receptors","volume":"61","author":"Zouridakis","year":"2009","journal-title":"IUBMB Life"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1782495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:12:14Z","timestamp":1779430334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1782495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":115,"alternative-id":["10.3389\/fphar.2026.1782495"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1782495","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1782495"}}